Home Programme About Performers Venue Registration Contact

Monday 3rd June 2013, Noon

„Single-use technology in biopharmaceutical manufacturing: Tomorrow“


Vaccines and cell therapeutics



Session Chair:
Regine Eibl, Zurich University of Applied Sciences, Switzerland


New developments and trends in upstreaming, downstreaming, formulation and filling

Session Chair:
Detlef Eisenkrätzer, Roche Diagnostics GmbH, Germany 

   

13:00- 13:30

Viral vaccine development and production: current state and trends

13:00- 13:25

New Levitronix single-use pump series PuraLev®: characteristics and investigations of mechanical stress

 

Alain Prolang,
GlaxoSmithKline, Belgium

 

Stephan C. Kaiser, Zurich University of Applied Sciences, Switzerland and Wolfgang Dornfeld, Levitronix GmbH, Switzerland

13:30- 14:00

Practical applications of single use technology for the production of recombinant VLP and nanoparticle vaccines

13:25- 15:50

Improved Bioreactor Design for Laboratory to Production Suite Operations

 

Timothy Hahn,
Novavax Inc., USA

 

Henry Charlton, Pall Corporation

14:00- 14:30

Development of a single-use system based production platform for stem cell expansion

13:50- 14:15

Eppendorf’s single-use solutions: rigid-wall bioreactors from 100mL- up to 50L

 

Christian van den Bos,
Lonza Cologne AG, Germany

 

Christof Knocke, Vaudaux Eppendorf AG, Switzerland

14:30- 15:00

hMSC production in disposable bioreactors with regards to GMP and PAT

14:15- 14:40

Linear scalability for viral entities production in iCELLis™ disposable fixed-bed bioreactor from bench-scale to industrial scale

 

Peter Czermak,
Technische Hochschule Mittelhessen and Kansas State University, Germany/USA

 

Mathieu Cesari, ATMI LifeSciences, Belgium

    14.40-
15.05
 

Next generation downstream template for continuous mAb processing

      Sébastien Ribault, Merck Millipore, France
       
15:00-
15:30
Coffee break and exhibition (Building GA)

 



Zum Hauptmenu
Zum Untermenu
Zum Inhalt